Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

International Conference on Nutrition in Medicine tackles trending health topics from ultra-processed foods to Ozempic in Washington, DC, Aug. 14-16 - EurekAlert!

Beyond Ozempic: New weight loss drug rivals surgery

Ozempic Without Nausea: Brain Cell Discovery Could Change Weight-Loss Drugs

Weight-Loss Drugs Like Ozempic Can Leave Lasting Damage in Your Mouth

Landmark Study Shows Ozempic May Treat This Deadly Liver Disease

Expert Reveals a Drug-Free Way to Mimic The Effects of Ozempic

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

People on Ozempic start disliking meat and fried foods. We're starting to learn why.

Ozempic and Wegovy ingredient may reverse signs of liver disease

Why Ozempic and Wegovy Might Change Your Favorite Food

Daily pill could replace weight-loss shots like Ozempic and Wegovy

Popular Weight Loss Drugs Like Ozempic May Trigger Depression, Doctors Warn

Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Weight-Loss Drugs Like Ozempic May Guard Against Dementia, Research Finds

Drugs like Ozempic and Wegovy could significantly cut dementia risk

Grow Your Own Ozempic? Students Engineer Plants to Produce Life-Saving Drugs

Do Ozempic and Wegovy really cause hair loss?

You could soon grow your own Ozempic-like medication - EurekAlert

New Protein Discovery Could Rival Ozempic With Fewer Side Effects

Ozempic is increasingly being linked to vision loss. What’s the truth?